Assessment of Safety, Tolerability, Immunogenicity, and Pharmacokinetics of AZD3427
Clinical trial NCT04630067 · COMPLETED
Trial details
- NCT number
- NCT04630067
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-17
- Primary completion
- 2022-09-14
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.